Paradigm Pharmaceuticals (ASX: PAR) conducting a clinical trial on the use of PPS to treat bone marrow oedema – Channel 7 News story
ASX:NOR Norwood Systems pleased to announce public beta of Corona Cloud and launch of World Phone 1.2
You must be logged in to post a comment.